Zentalis Pharmaceuticals ... (ZNTL)
NASDAQ: ZNTL
· Real-Time Price · USD
1.59
0.11 (7.43%)
At close: Aug 15, 2025, 3:59 PM
1.59
-0.31%
After-hours: Aug 15, 2025, 04:10 PM EDT
Zentalis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 26.86M | 26.86M | 67.42M | 42.66M | 42.66M | 42.66M | 2.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.06M | 1.23M | 1.29M | 1.31M | 1.34M | 1.35M | 1.39M | 1.41M | 1.44M | 1.44M | 1.43M | 1.28M | 1.04M | 809K | 544K | 335K | 198K | 79K |
Gross Profit | 26.12M | 25.95M | 66.45M | 41.35M | 41.33M | 41.31M | 715K | -1.41M | -1.44M | -1.44M | -1.43M | -1.28M | -1.04M | -809K | -544K | -335K | -198K | -79K |
Operating Income | -182.96M | -212.05M | -191.19M | -209.27M | -220.55M | -259.32M | -299.51M | -283.34M | -274.82M | -234.36M | -227.29M | -223.73M | -232.4M | -224.07M | -216.54M | -208.59M | -180.49M | -152.74M |
Interest Income | n/a | n/a | n/a | n/a | 7.21K | 11.66K | 11.66K | 12.15K | 6.85K | 2.4K | 2.4K | 1.91K | n/a | n/a | 143K | 143K | 143K | 143K |
Pretax Income | -163.01M | -224.15M | -165.69M | -179.09M | -194.41M | -205.87M | -276.89M | -264.34M | -261.12M | -224.69M | -221.3M | -220.88M | -179.78M | -171.76M | -164.56M | -156.38M | -179.84M | -152.12M |
Net Income | -162.78M | -224.19M | -165.84M | -179.28M | -194.65M | -218.9M | -289.92M | -277.17M | -273.77M | -224.3M | -220.83M | -222.73M | -174.79M | -166.31M | -158.72M | -148.97M | -179.33M | -151.62M |
Selling & General & Admin | 73.64M | 81.95M | 86.79M | 62.81M | 64.16M | 63.06M | 64.01M | 59.12M | 55.18M | 59.16M | 54.55M | 53.17M | 50.03M | 40.76M | 40.94M | 41.91M | 43.14M | 42.7M |
Research & Development | 124.65M | 145.43M | 167.77M | 186.35M | 196.29M | 190.59M | 189.59M | 178.65M | 174.06M | 175.21M | 172.73M | 170.56M | 182.37M | 183.32M | 175.6M | 166.68M | 137.35M | 110.04M |
Other Expenses | 11.53M | 11.53M | 3.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -44K | -44K | -44K | -44K |
Operating Expenses | 209.83M | 238.92M | 258.3M | 249.17M | 260.45M | 253.65M | 253.6M | 237.77M | 229.25M | 234.36M | 227.29M | 223.73M | 232.4M | 224.07M | 216.54M | 208.59M | 180.49M | 152.74M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 345K | 710.1K | 5.17M | 5.9M | 5.56M | 5.19M | 739K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -324K | -661K | -661K | -661K | -337K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 209.83M | 238.92M | 258.62M | 249.83M | 261.11M | 254.31M | 253.94M | 237.77M | 229.25M | 234.36M | 227.29M | 223.73M | 232.4M | 224.07M | 216.54M | 208.59M | 180.49M | 152.74M |
Income Tax Expense | -232K | 34K | 177K | 247K | 305K | -566K | -601K | -826K | -1.02M | -394K | -469K | 50K | -488K | -460K | -297K | -30K | 685K | 640K |
Shares Outstanding (Basic) | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 70.9M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
Shares Outstanding (Diluted) | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 71.19M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
EPS (Basic) | -2.27 | -3.14 | -2.33 | -2.52 | -2.75 | -3.36 | -4.53 | -4.48 | -4.61 | -3.99 | -4.23 | -4.53 | -3.7 | -3.81 | -3.78 | -3.68 | -4.5 | -3.94 |
EPS (Diluted) | -2.27 | -3.14 | -2.33 | -2.52 | -2.75 | -3.36 | -4.53 | -4.48 | -4.61 | -3.99 | -4.23 | -4.53 | -3.7 | -3.81 | -3.78 | -3.68 | -4.5 | -3.94 |
EBITDA | -178.43M | -207.35M | -186.17M | -207.96M | -219.22M | -212.4M | -252.55M | -236.36M | -227.81M | -232.92M | -225.86M | -222.36M | -231.28M | -223.18M | -215.91M | -208.23M | -180.21M | -152.53M |
EBIT | -171.43M | -200.52M | -187.46M | -209.27M | -220.55M | -213.75M | -253.94M | -237.77M | -229.25M | -234.36M | -227.29M | -223.73M | -232.4M | -224.07M | -216.54M | -208.59M | -180.49M | -152.74M |
Depreciation & Amortization | 1.06M | 1.23M | 1.29M | 1.31M | 1.34M | 1.35M | 1.39M | 1.41M | 1.44M | 1.44M | 1.43M | 1.28M | 1.04M | 809K | 544K | 368K | 282K | 201K |